Literature DB >> 15210953

Apolipoprotein CIII promotes Ca2+-dependent beta cell death in type 1 diabetes.

Lisa Juntti-Berggren1, Essam Refai, Ioulia Appelskog, Mats Andersson, Gabriela Imreh, Nancy Dekki, Sabine Uhles, Lina Yu, William J Griffiths, Sergei Zaitsev, Ingo Leibiger, Shao-Nian Yang, Gunilla Olivecrona, Hans Jörnvall, Per-Olof Berggren.   

Abstract

In type 1 diabetes (T1D), there is a specific destruction of the insulin secreting pancreatic beta cell. Although the exact molecular mechanisms underlying beta cell destruction are not known, sera from T1D patients have been shown to promote Ca(2+)-induced apoptosis. We now demonstrate that apolipoprotein CIII (apoCIII) is increased in serum from T1D patients and that this serum factor both induces increased cytoplasmic free intracellular Ca(2+) concentration ([Ca(2+)](i)) and beta cell death. The apoCIII-induced increase in [Ca(2+)](i) reflects an activation of the voltage-gated L-type Ca(2+) channel. Both the effects of T1D sera and apoCIII on the beta cell are abolished in the presence of antibody against apoCIII. Increased serum levels of apoCIII can thus account for the increase in beta cell [Ca(2+)](i) and thereby beta cell apoptosis associated with T1D.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15210953      PMCID: PMC454169          DOI: 10.1073/pnas.0403551101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Phospholipase activity of milk lipoprotein lipase.

Authors:  G Bengtsson-Olivecrona; T Olivecrona
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

Review 2.  Mechanisms involved in the regulation of the insulin secretory process.

Authors:  S Efendic; H Kindmark; P O Berggren
Journal:  J Intern Med Suppl       Date:  1991

3.  Apolipoprotein A-I, A-II, B, C-II, and C-III in children with insulin-dependent diabetes mellitus.

Authors:  N al Muhtaseb; A al Yousuf; J S Bajaj
Journal:  Pediatrics       Date:  1992-05       Impact factor: 7.124

4.  The complete amino acid sequence of alanine apolipoprotein (apoC-3), and apolipoprotein from human plasma very low density lipoproteins.

Authors:  H B Brewer; R Shulman; P Herbert; R Ronan; K Wehrly
Journal:  J Biol Chem       Date:  1974-08-10       Impact factor: 5.157

Review 5.  Apoprotein C metabolism in man.

Authors:  P J Nestel; N H Fidge
Journal:  Adv Lipid Res       Date:  1982

6.  Serum lipoproteins and apolipoproteins in rats with streptozotocin-induced diabetes.

Authors:  H Bar-On; P S Roheim; H A Eder
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

7.  Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice.

Authors:  Y Ito; N Azrolan; A O'Connell; A Walsh; J L Breslow
Journal:  Science       Date:  1990-08-17       Impact factor: 47.728

8.  Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein.

Authors:  R C Kowal; J Herz; K H Weisgraber; R W Mahley; M S Brown; J L Goldstein
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

9.  Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics.

Authors:  E R Briones; S J Mao; P J Palumbo; W M O'Fallon; W Chenoweth; B A Kottke
Journal:  Metabolism       Date:  1984-01       Impact factor: 8.694

10.  Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.

Authors:  M L Kashyap; L S Srivastava; B A Hynd; P S Gartside; G Perisutti
Journal:  J Lipid Res       Date:  1981-07       Impact factor: 5.922

View more
  30 in total

1.  A hybrid approach to protein differential expression in mass spectrometry-based proteomics.

Authors:  Xuan Wang; Gordon A Anderson; Richard D Smith; Alan R Dabney
Journal:  Bioinformatics       Date:  2012-04-19       Impact factor: 6.937

2.  Surface rheology and adsorption kinetics reveal the relative amphiphilicity, interfacial activity, and stability of human exchangeable apolipoproteins.

Authors:  Victor Martin Bolanos-Garcia; Anne Renault; Sylvie Beaufils
Journal:  Biophys J       Date:  2007-11-09       Impact factor: 4.033

3.  The pancreatic β-cell in deadly encounter with apolipoprotein CIII.

Authors:  Lisa Juntti-Berggren; Yusuf Ali; Per-Olof Berggren
Journal:  Cell Cycle       Date:  2015-06-23       Impact factor: 4.534

4.  Lowering apolipoprotein CIII delays onset of type 1 diabetes.

Authors:  Rebecka Holmberg; Essam Refai; Anders Höög; Rosanne M Crooke; Mark Graham; Gunilla Olivecrona; Per-Olof Berggren; Lisa Juntti-Berggren
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

5.  Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Sarah A Aroner; Jeremy D Furtado; Frank M Sacks; Michael Y Tsai; Kenneth J Mukamal; Robyn L McClelland; Majken K Jensen
Journal:  Diabetologia       Date:  2019-04-04       Impact factor: 10.122

6.  Transthyretin binds to glucose-regulated proteins and is subjected to endocytosis by the pancreatic β-cell.

Authors:  Nancy Dekki; Essam Refai; Rebecka Holmberg; Martin Köhler; Hans Jörnvall; Per-Olof Berggren; Lisa Juntti-Berggren
Journal:  Cell Mol Life Sci       Date:  2011-12-20       Impact factor: 9.261

7.  Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes.

Authors:  Karin Åvall; Yusuf Ali; Ingo B Leibiger; Barbara Leibiger; Tilo Moede; Meike Paschen; Andrea Dicker; Elisabetta Daré; Martin Köhler; Erwin Ilegems; Midhat H Abdulreda; Mark Graham; Rosanne M Crooke; Vanessa S Y Tay; Essam Refai; Stefan K Nilsson; Stefan Jacob; Lars Selander; Per-Olof Berggren; Lisa Juntti-Berggren
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205

Review 8.  Ionic mechanisms in pancreatic β cell signaling.

Authors:  Shao-Nian Yang; Yue Shi; Guang Yang; Yuxin Li; Jia Yu; Per-Olof Berggren
Journal:  Cell Mol Life Sci       Date:  2014-07-23       Impact factor: 9.261

9.  Role of MAPK in apolipoprotein CIII-induced apoptosis in INS-1E cells.

Authors:  E-ri M Sol; Tea Sundsten; Peter Bergsten
Journal:  Lipids Health Dis       Date:  2009-02-05       Impact factor: 3.876

10.  Lipotoxicity and decreased islet graft survival.

Authors:  Cristiane B Leitão; Karina Bernetti; Thipaporn Tharavanij; Pablo Cure; Vincenzo Lauriola; Per-Olof Berggren; Camillo Ricordi; Rodolfo Alejandro
Journal:  Diabetes Care       Date:  2009-12-15       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.